| 000 | 01583 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250512000835.0 | ||
| 264 | 0 | _c19851105 | |
| 008 | 198511s 0 0 eng d | ||
| 022 | _a0012-186X | ||
| 024 | 7 |
_a10.1007/BF00283143 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBallmann, M | |
| 245 | 0 | 0 |
_aChanges in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat. _h[electronic resource] |
| 260 |
_bDiabetologia _cJun 1985 |
||
| 300 |
_a355-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xmetabolism |
| 650 | 0 | 4 |
_aDigestive System _xmetabolism |
| 650 | 0 | 4 |
_aDuodenum _xmetabolism |
| 650 | 0 | 4 |
_aGastric Mucosa _xmetabolism |
| 650 | 0 | 4 |
_aIleum _xmetabolism |
| 650 | 0 | 4 |
_aIntestine, Small _xmetabolism |
| 650 | 0 | 4 |
_aJejunum _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNiacinamide _xpharmacology |
| 650 | 0 | 4 | _aOrgan Size |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aSomatostatin _xmetabolism |
| 650 | 0 | 4 |
_aStomach _xpathology |
| 650 | 0 | 4 |
_aStreptozocin _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSubstance P _xmetabolism |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xmetabolism |
| 700 | 1 | _aConlon, J M | |
| 773 | 0 |
_tDiabetologia _gvol. 28 _gno. 6 _gp. 355-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00283143 _zAvailable from publisher's website |
| 999 |
_c2418978 _d2418978 |
||